Search Results for: Kephir concentrated
in virology, bacterial infection and different adjuvant platforms. we now have three global r&d hubs: rockville, usa (new in ); rixensart, belgium and siena, italy, which are focused on discovering and developing novel vaccines across a range of pressing public health threats. our efforts are concentrated
in virology, bacterial infection and different adjuvant platforms. we now have three global r&d hubs: rockville, usa (new in ); rixensart, belgium and siena, italy, which are focused on discovering and developing novel vaccines across a range of pressing public health threats. our efforts are concentrated...
https://www.gsk.com/en-gb/about-us/vaccines/